Precision Optics (POCI) Stock News

Precision Optics (NASDAQ: POCI) announced a product development order dated Nov 7, 2025 to build compact optical sub-assemblies for an augmented reality (AR) system intended for US Air Force fighter pilot in-air training.

The initial $723,000 development order covers design, prototyping and qualification of next-generation, reduced size/weight/power optical systems to enable pilots to wear AR headsets during flight and reduce secondary-aircraft training needs.

Precision Optics (Nasdaq: POCI) scheduled a conference call to discuss its first quarter fiscal 2026 financial results on Thursday, November 13, 2025 at 5:00 p.m. ET. The company said it will release results and file its Form 10-Q after market close on November 13, 2025, followed by the call.

Access: live dial-in at (844) 735-3662 or (412) 317-5705, live webcast at https://app.webinar.net/3PyMqXG06ZY. A teleconference replay will be available for seven days at (877) 344-7529 or (412) 317-0088 (access code 7772062); webcast replay available at the same webinar link.

Precision Optics (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, has announced its participation in the virtual Lytham Partners Fall 2025 Investor Conference on September 30, 2025.

The company will deliver a webcast presentation at 10:15 a.m. ET and conduct one-on-one meetings with investors throughout the event. Interested parties can access the webcast through the conference website, with replay available after the event.

Precision Optics (NASDAQ: POCI) reported Q4 and FY 2025 financial results, with record Q4 revenue of $6.2 million, up 48% year-over-year. FY 2025 revenue was $19.1 million, with production revenue growing 34% to $14.2 million. The company reported a net loss of $(5.8) million for FY 2025.

For FY 2026, POCI projects revenue exceeding $25 million (31% growth) and expects gross margins to improve to approximately 30% from 18% in FY 2025. The company anticipates Adjusted EBITDA of $0.5 million in FY 2026, compared to $(3.7) million in FY 2025.

Additionally, POCI appointed Joseph Traut as new Chief Operating Officer effective October 1, 2025, granting him inducement stock options for 60,000 shares.

Precision Optics (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, has scheduled its fourth quarter and fiscal year 2025 financial results conference call for September 29, 2025, at 5:00 p.m. ET.

The company will release its financial results and file its 10-K after market close on the same day. Investors can join via phone at (844) 735-3662 or (412) 317-5705, or through a live webcast. A replay will be available for seven days following the call.

Precision Optics (Nasdaq: POCI), a designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, will participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025.

The company's virtual presentation is scheduled for 9:30 a.m. ET and will be accessible through the conference website. A replay of the webcast will be available following the presentation.

Precision Optics Corporation (NASDAQ: POCI), a designer and manufacturer of advanced optical instruments, announced a strategic relocation of its corporate offices from Gardner, MA to Littleton, MA, effective August 1st, 2025. The move will separate corporate functions, including executive leadership, engineering, and business operations, from production facilities. This strategic decision allows for expanded production capabilities at the existing Gardner facility to address the company's record-high production backlog. Additionally, the new Littleton location, along with a facility in South Portland, Maine, positions the company to access a broader engineering talent pool for its product development initiatives.

Precision Optics Corporation (NASDAQ: POCI), a specialized manufacturer of advanced optical instruments for medical and defense/aerospace sectors, has announced its participation in the upcoming Lytham Partners Spring 2025 Investor Conference on May 29, 2025.

The company will deliver a webcast presentation at 10:15 a.m. ET and conduct one-on-one meetings with investors throughout the virtual event. Interested participants can access the webcast through the conference website or arrange individual meetings with management through Lytham Partners.

Precision Optics Corporation (NASDAQ: POCI) reported Q3 FY2025 financial results with significant challenges and strategic developments. Revenue declined to $4.2 million from $5.2 million year-over-year, with production revenue at $3.3 million and engineering revenue at $0.9 million. The company faced setbacks with gross margins dropping to 10.0% from 35.5%, resulting in a net loss of ($2.1) million. Despite challenges, POCI secured a Main Purchase Agreement with a top-tier aerospace company, guaranteeing minimum purchases of nearly $4 million annually through 2026. The company launched the Unity Imaging Platform for endoscopic imaging devices and completed a $5.1 million common stock offering. Production issues with a single-use cystoscope line were resolved, with doubled throughput after February restart. Management expects improved Q4 performance with sequential revenue growth and break-even or better adjusted EBITDA.